Referenties
1National Stroke Association. What is Stroke. Available at: www.stroke.org. Accessed.March 2020
2Truelsen T, Piechowski-Jo´z´wiakb,C, Bonitaa R et al. Stroke incidence and prevalence in Europe: a review of available data. European Journal of Neurology 2006, 13: 581-598.
3Gillard PJ, Sucharew H, Kleindorfer D, et al. The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study. Health Qual Life Outcomes. 2015;13:159.
4Welmer et al. Spasticity and Its association with functioning and health-related quality of life 18 months after stroke. Cerebrovasc Dis 2006;21:247–53.
5Mayo Clinic. Stroke. Available at: www.mayoclinic.org. Accessed March 2020
6Dvorak EM, Ketchum NC, McGuire JR. The underutilization of intrathecal baclofen in poststroke spasticity. Top Stroke Rehabil.2011;18(3):195–202.
7Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin. Rehabil. 2002;16(5):515-522.
8Sommerfeld DK, Gripenstedt U, Welmer AK. Spasticity after stroke: an overview of prevalence, test instruments, and treatments. Am. J. Phys. Med. Rehabil. 2012;91(9):814-820.
9Lundstrom E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur. J. Neurol. 2008;15(6):533-539.
10Urban PP, Wolf T, Uebele M, et al. Occurence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41(9):2016-2020.
11World Stroke Organization – Global Stroke Fact Sheet 2019 - V. Feigin et al. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016 NewEngl J Med 2018;379:2429-2437